10.1002/anie.201712340
Angewandte Chemie International Edition
COMMUNICATION
Chem. Soc. Rev. 2014, 43, 1660–1733; d) S. Carboni, C. Gennari, L.
Pignatoro, U. Piarulli, Dalton Trans. 2011, 40, 4355–4373.
In summary, we have shown that a hydrogen bonding ligand
serves as a key element in controlling the selectivity of a
manganese porphyrin catalyzed CH oxygenation reaction. 3,3-
Disubstituted 3,4-dihydroquinolones reacted exclusively and with
high enantioselectivity at position C4 of the heterocyclic
skeleton. Evidence was collected that the reaction occurs via an
oxygen transfer from a manganese oxo complex by a rebound
mechanism. It appears as if the hydrogen bonding event lowers
the activation barrier for attack at a specific CH bond and it is
likely that this mode of action will apply also to related reactions.
More importantly, it seems possible to address distinct CH
positions in a given substrate by spatially adjusting the position
of the catalytic entity relative to the hydrogen bonding substrate.
[9]
For previous work on site-selective oxygenation reactions, mediated by
catalysts with a remote binding site, see: a) R. Breslow, X. Zhang, Y.
Huang, J. Am. Chem. Soc. 1997, 119, 4535-4536; b) J. Yang, R.
Breslow, Angew. Chem., Int. Ed. 2000, 39, 2692-2694; Angew. Chem.
2000, 112, 2804-2806; c) B. Schönecker, T. Zheldakova, Y. Liu, M.
Kötteritzsch, W. Günther, H. Görls, Angew. Chem. Int. Ed. 2003, 42,
3240-3244; Angew. Chem. 2003, 115, 3361-3365; d) S. Das, C. D.
Incarvito, R. H. Crabtree, G. W. Brudvig, Science 2006, 312, 1941-
1943; e) D. Font, M. Canta, M. Milan, O. Cussó, X. Ribas, R. J. M. Klein
Gebbink, M. Costas, Angew. Chem. Int. Ed. 2016, 55, 5776-5779;
Angew. Chem. 2016, 128, 5870-5873. For a recently reported highly
enantiotopos-selective Mn-catalyzed oxygenation reaction of methylene
compounds to ketones, see ref.[6h]
[10] a) P. Fackler, C. Berthold, F. Voss, T. Bach, J. Am. Chem. Soc. 2010,
132, 15911–15913; b) P. Fackler, S. M. Huber, T. Bach, J. Am. Chem.
Soc. 2012, 134, 12869–12878; c) J. R. Frost, S. M. Huber, S.
Breitenlechner, C. Bannwarth, T. Bach, Angew. Chem. Int. Ed. 2015,
54, 691-695; Angew. Chem. 2015, 127, 701-705.
Acknowledgements
Financial support by the Deutsche Forschungsgemeinschaft
(grant Ba 1372-17) is gratefully acknowledged. O. Ackermann
and J. Kudermann are acknowledged for their help with the
HPLC and GLC analyses.
[11] a) J. T. Groves, W. J. Kruper, R. C. Haushalter, J. Am. Chem. Soc.
1980, 102, 6375-6377; b) J. T. Groves, J. B. Lee, S. S., J. Am. Chem.
Soc. 1997, 119, 6269-6273; c) N. Jin, M. Ibrahim, T. Spiro, J. T. Groves,
J. Am. Chem. Soc. 2007, 129, 12416-12417.
[12] For reviews on functionalized and chiral porphyrins, see: a) S. Hiroto, Y.
Miyake, H. Shinokubo, Chem. Rev. 2017, 117, 2910-3043; b) K.
Rybicka-Jasińska, W. Ciszewski, D. T. Gryko, D. Gryko, J. Porphyrins
Phthalocyanines 2016, 20, 76-95; c) M. O. Senge, Chem. Commun.
2011, 47, 1943-1960.
Keywords: enantioselectivity • hydrogen bonds • manganese •
oxygenation • porphyrinoids
[1]
Reviews on CH oxygenation reactions: a) G. B. Shul’pin, Catalysts
2016, 6, 50; b) R. Irie, C–O Bond Formation by C–H Activation. In
Comprehensive Chiralitiy; Vol. 5; (Eds.: E. M. Carreira, H. Yamamoto),
Elsevier: Amsterdam, 2012, pp. 36–68; c) M. Costas, Coord. Chem.
Rev. 2011, 255, 2912–2932; d) T. Newhouse, P. S. Baran, Angew.
Chem. Int. Ed. 2011, 50, 3362-3374; Angew. Chem. Int. Ed. 2011, 123,
3422-3435; e) C.-M. Che, V. K.-Y. Lo, C.-Y. Zhou, J.-S. Huang, Chem.
Soc. Rev. 2011, 40, 1950–1975; f) H. Lu, P. Zhang, Chem. Soc. Rev.
2011, 40, 1899–1909.
[13] G. Sargsyan, B. M. Leonhard, J. Kubelka, M. Balaz, Chem. Eur. J.
2014, 20, 1878-1892.
[14] D. Lahaye, K. Muthukumaran, C.-H. Hung, D. Gryko, J. S. Rebouças, I.
Spasojević, I. Batinić-Haberle, J. S. Lindsey, Bioorg. Med. Chem. 2007,
15, 7066-7086.
[15] a) L. J. Boucher, J. J. Katz, J. Am. Chem. Soc. 1967, 89, 1340-1345; b)
B. De Poorter, B. Meunier, J. Chem. Soc., Perkin Trans. 2, 1985, 1735-
1740.
[16] More than 100 biologically active compounds of this class are known.
For two recent examples, see: a) T. Takai, T. Koike, M. Nakamura, Y.
Kajita, T. Yamashita, N. Taya, T. Tsukamoto, T. Watanabe, K.
Murakami, T. Igari, M. Kamata, Biorg. Med. Chem. 2016, 24, 3192-
3206; b) S. Susanta, A. Chandrasekhar, S. Sanjita, H. Subramanya,
Heterocyclic Derivatives as Bromodomain Inhibitors. WO Patent
2015/104653, June 16, 2015.
[2]
a) R. Zhang, W.-Y. Yu, T.-S. Lai, C.-M. Che, Chem. Commun. 1999,
1791–1792; b) Z. Gross, S. Ini, Org. Lett. 1999, 1, 2077–2080; c) R.
Zhang, W.-Y. Yu, C.-M. Che, Tetrahedron: Asymmetry 2005, 16, 3520–
3526.
[3]
[4]
[5]
[6]
Recent review on Ru-oxo complexes: T. Ishizuka, H. Kotani, T. Kojima,
Dalton Trans. 2016, 45, 16727-16750.
a) J. T. Groves, P. Viski, J. Am. Chem. Soc. 1989, 111, 8537–8538; b)
J. T. Groves, P. Viski, J. Org. Chem. 1990, 55, 3628–3634.
[17] a) M. D. Ferretti, A. T. Neto, A. F. Morel, T. S. Kaufman, E. L. Larghi,
Eur. J. Med. Chem. 2014, 81, 253-266; b) J. N. Papillon et al., J. Med.
Chem. 2015, 58, 4749-4770.
Recent review on Fe-catalyzed oxygenation reactions: A. C. Lindhorst,
S. Haslinger, F. E. Kühn, Chem. Commun. 2015, 51, 17193-17212.
a) K. Hamachi, R. Irie, T. Katsuki, Tetrahedron Lett. 1996, 37, 4979–
4982; b) L. Halterman, S.-T. Jan, H. L. Nimmons, D. J. Standlee, M. A.
Khan, Tetrahedron 1997, 53, 11257–11276; c) N. Komiya, S. Noji, S.-I.
Muraheshi, Tetrahedron Lett. 1998, 39, 7921–7924; d) T. Hamada, R.
Irie, J. Mihara, K. Hamachi, T. Katsuki, Tetrahedron 1998, 54, 10017–
10028; e) S.-I. Murahashi, S. Noji, N. Komiya, Adv. Synth. Catal. 2004,
346, 195–198; f) H. Srour, P. Le Maux, G. Simonneaux, Inorg. Chem.
2012, 51, 5850–5856; g) P. Le Maux, H. Srour, G. Simonneaux,
Tetrahedron 2012, 68, 5824–5828; h) M. Milan, M. Bietti, M. Costas,
ACS Cent. Sci. 2017, 3, 196-204.
[18] Parent 3,4-dihydroquinolone without substituents at position C-3 (R =
H) and C-7 (X = H) underwent the oxygenation reaction with high
enantioselectivity (95% ee) but the major product resulted from
subsequent water elimination to quinolone.
[19] A similar s factor was determined in a kinetic resolution experiment with
a
chiral 4-methylsubstituted 3,4-dihydroquinolone (see Supporting
Information for further details).
[20] a) X. Huang, J. T. Groves, Biol. Inorg. Chem. 2017, 22, 185-207; b) W.
Liu, M.-J. Cheng, R. J. Nielsen, W. A. Goddard, III, J. T. Groves, ACS
Catalysis 2017, 7, 4182-4188 and refs. cited therein.
[21] D. C. Nonhebel, Chem. Soc. Rev. 1993, 22, 347-359.
[22] a) A. Sorokin, A. Robert, B. Meunier, J. Am. Chem. Soc. 1993, 115,
7293-7299; b) K. W. Wong, T.-H. Chen, W. Luo, H. Jeddi, R. Zhang,
Inorg. Chim. Acta 2015, 430, 176-183.
[7]
[8]
Recent reviews on Mn-catalyzed oxidation and oxygenation reactions:
a) M. M. Najafpour, G. Renger, M. Holynska, A. N. Moghaddam, E.-M.
Aro, R. Carpentier, H. Nishihara, J. J. Eaton-Rye, J.-R. Shen, S. I.
Allakhverdiev, Chem. Rev. 2016, 116, 2886-2936; b) R. V. Ottenbacher,
E. P. Talsi, K. P. Bryliakov, Molecules 2016, 21, 1454/1-1454/16.
For recent reviews, see: a) H. J. Davis, R. J. Phipps, Chem. Sci. 2017,
8, 864-877; b) P. Dydio, J. N. H. Reek, Chem. Sci. 2014, 5, 2135–2145;
c) M. Raynal, P. Ballester, A. Videl-Ferran, P. W. N. M. Van Leeuwen,
[23] Preliminary DFT calculations were performed with the M06L-D3
functional, the SDD basis set (including pseudopotential) for Mn and
the 6-31G* basis set for all other atoms.
This article is protected by copyright. All rights reserved.